CHDI is interested in supporting ideas proposed by the external scientific community. However, letters of intent are currently not being accepted for either preclinical or clinical research. If you have a preclinical research proposal that you consider would contribute to our efforts to accelerate therapeutics for HD, please contact the CHDI Science Director that you think would have the most relevant interest and expertise – a listing of scientific staff and their backgrounds is here. For specific inquiries regarding clinical studies, please contact us at
We also collaborate with biotech and pharmaceutical companies interested in developing treatments for HD. Interested parties should contact the CHDI Outreach Team.